Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Ankli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|March 24, 2016
[Current epidemiology of gout]Barbara Ankli
Therapeutische Umschau. Revue Therapeutique|November 7, 2024
[Gout and Nutrition]Barbara Ankli
Therapeutische Umschau. Revue Therapeutique|January 20, 2023
[Update Gout]Barbara Ankli, Thomas Daikeler
Therapeutische Umschau. Revue Therapeutique|March 24, 2016
[Gout management: an update]Barbara Ankli, Stephan Krähenbühl
Annals of the Rheumatic Diseases|August 7, 2015
Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasomeArun Cumpelik, Barbara Ankli, Daniel Zecher, et al.
Annals of Neurology|October 3, 2023
Association of Chronic Pain with Biomarkers of Neurodegeneration, Microglial Activation, and Inflammation in Cerebrospinal Fluid and Impaired Cognitive FunctionAngélique Sadlon, Petros Takousis, Barbara Ankli, et al.
Swiss Medical Weekly|September 3, 2019
The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohortBarbara Ankli, Christoph T Berger, Nicolas Haeni, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|March 24, 2016
[Current epidemiology of gout]Barbara Ankli
Therapeutische Umschau. Revue Therapeutique|November 7, 2024
[Gout and Nutrition]Barbara Ankli
Therapeutische Umschau. Revue Therapeutique|January 20, 2023
[Update Gout]Barbara Ankli, Thomas Daikeler
Therapeutische Umschau. Revue Therapeutique|March 24, 2016
[Gout management: an update]Barbara Ankli, Stephan Krähenbühl
Annals of the Rheumatic Diseases|August 7, 2015
Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasomeArun Cumpelik, Barbara Ankli, Daniel Zecher, et al.
Annals of Neurology|October 3, 2023
Association of Chronic Pain with Biomarkers of Neurodegeneration, Microglial Activation, and Inflammation in Cerebrospinal Fluid and Impaired Cognitive FunctionAngélique Sadlon, Petros Takousis, Barbara Ankli, et al.
Swiss Medical Weekly|September 3, 2019
The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohortBarbara Ankli, Christoph T Berger, Nicolas Haeni, et al.
Pageof 1